两种人工肝治疗急性肝衰竭的比较:一项回顾性观察性研究
Xiulian Wu1, Dongxia Wu2, Xiaoqing Sun1
1Department of Critical Care Medicine, Beijing You'an Hospital, Affiliated to Capital Medical University, Beijing, China.
Nursing in critical care
|February 8, 2026
概括
双等离子分子吸附系统 (DPMAS) 与等离子交换 (PE) 结合,对肝功能衰竭有希望,但单独的PE可能会在某些标志物上提供更好的改善. 专业护理对于DPMAS+PE疗效至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 人工器官技术的人工器官技术
- 关键护理医学 关键护理医学
背景情况:
- 由于代谢,解毒和合成功能障碍,肝衰竭的死亡率很高 (60%-90%).
- 双等离子分子吸附系统 (DPMAS) 是一种新兴的人工肝技术,通常用于与等离子交换 (PE) 进行交换.
- DPMAS可能无法补充像白蛋白和凝血因子这样的必需物质,因此需要仅使用PE进行比较研究.
研究的目的:
- 研究DPMAS+PE与单独PE在急性药物诱导肝损伤患者中的临床有效性和护理考虑.
- 为了比较这些人工肝治疗对肝功能和凝血参数的影响.
主要方法:
- 对57名肝衰竭患者在ICU中的临床数据的回顾性分析.
- 患者被分为一个PE组 (n=14) 和一个DPMAS+PE组 (n=43).
- 治疗前后的肝功能 (ALT,AST,TBIL) 和凝血 (INR,前激素活性) 指数的比较.
主要成果:
- 在ALT,AST或TBIL中没有显著的治疗前差异.
- DPMAS + PE在治疗后降低ALT和AST水平方面表现出更好的效果.
- 单纯的PE在改善TBIL和INR水平方面显示出更大的有效性.
结论:
- 两种人工肝治疗 (PE和DPMAS + PE) 都可以改善肝功能标志物,并支持肝衰竭患者的康复.
- DPMAS + PE需要专门的护理人员来监测电路压力,凝血和抗凝血,以确保安全性和有效性.
- 这些疗法支持等待肝移植的患者.
相关概念视频
Liver Histology
4.5K
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Hepatocytes perform a variety of essential functions. They secrete...
4.5K
Liver Physiology
3.8K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.8K
Liver Regeneration
4.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.4K
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II
1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V
510
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
510


